Pharmacoepidemiology Study Design & Safety Signal Assessment
Design pharmacoepidemiology studies to assess drug safety signals
What You Can Do
You can design rigorous observational and retrospective cohort studies that meet FDA and EMA regulatory standards, complete with detailed statistical analysis plans and safety assessment frameworks. Claude generates structured study protocols, pre-specifies safety signal detection methodologies, and produces regulatory-ready documentation that accelerates your pathway from research hypothesis to pharmacovigilance submission.
Features
Generate comprehensive protocols with study population definitions, inclusion/exclusion criteria, and outcome specifications aligned with ICH-GCP standards
Systematize adverse event detection using disproportionality analysis, temporal relationship assessment, and dose-response evaluation frameworks
Structure pre-specified statistical approaches including propensity score matching, instrumental variables, and confounder adjustment strategies
Produce agency-ready study synopses, statistical analysis summaries, and safety update narratives formatted for FDA/EMA submission
Develop REMS and risk evaluation frameworks based on signal severity, population vulnerability, and benefit-risk assessment matrices
Generate validation workflows for cohort definitions, outcome classification, and medication exposure ascertainment across healthcare databases
Construct structured frameworks for comparative effectiveness and safety profiling across therapeutic alternatives
Example Output
Study Protocol Excerpt:
- Population: Patients aged ≥18 with diagnosis code [ICD-10] initiating [drug name], excluding prior use in last 12 months
- Primary outcome: Hospitalization for [adverse event], defined by claims/EHR codes [list], with 30-day lookback
- Statistical analysis: Propensity score adjustment using logistic regression (14 baseline covariates), stratified Cox regression with 95% CI estimation
Safety Signal Report:
- Disproportionality: ROR = 2.4 (95% CI: 1.8–3.1) for hepatotoxicity in VigiBase™ 2024 subset
- Temporal assessment: Median onset 45 days post-initiation; rechallenge data supports causality (Naranjo score 7/9)
- Recommendation: Add hepatic impairment to contraindications section; implement liver function monitoring protocol
Regulatory REMS Documentation:
- ETASU requirements: Risk-benefit profile justifies restricted distribution; recommend risk categorization framework and provider certification pathway
What's Included
- SKILL.md: Complete pharmacoepi study design methodology, signal assessment decision trees, and regulatory mapping
- Study Protocol Template: ICH-GCP compliant protocol structure with outcome and covariate specifications
- Safety Signal Assessment Checklist: Disproportionality analysis, temporal relationship, dose-response evaluation workflow
- Statistical Analysis Plan Template: Pre-specified statistical approaches with sensitivity analysis matrices
- Regulatory Submission Framework: FDA Form 1571, EMA CTD safety summary structure, and REMS documentation templates
- Data Quality Validation Checklist: Cohort definition validation, outcome classification verification, exposure ascertainment audit trail
- Comparative Safety Analysis Worksheet: Structured framework for multi-drug safety profiling
- Example Study Protocols: Real-world redacted protocol examples across indication types
Who It's For
- Pharmacoepidemiologists — Design observational studies and execute post-market surveillance programs
- Clinical Safety Officers — Assess emerging safety signals and develop risk minimization strategies
- Regulatory Affairs Specialists — Prepare agency submissions with pre-defined protocols and statistical plans
- Medical Affairs Teams — Support comparative safety assessments and REMS documentation
- Academic Researchers — Develop grant applications and study protocols for drug safety research
Best For
- Designing post-approval pharmacoepidemiology studies for FDA/EMA reporting
- Assessing and characterizing drug safety signals from spontaneous reporting or claims data
- Pre-specifying statistical analysis plans and study protocols before data access
- Developing Risk Evaluation and Mitigation Strategy (REMS) frameworks and justifications
- Conducting comparative safety analyses across competing therapeutic agents
You might also like
Create comprehensive, culturally competent chronic disease prevention programs tailored to your target population. You can generate evidence-based patient education materials, design personalized behavior change interventions, and build clinically rigorous implementation roadmaps. The skill integrates best practices in health psychology, motivational interviewing, and cultural competency to produce programs that drive real behavior change and measurable health outcomes.
You can quickly organize infectious disease outbreak data into structured investigative frameworks, synthesize complex epidemiological findings into coherent narratives, and produce comprehensive situational reports that prioritize key risks and actionable response strategies. This skill transforms scattered clinical, laboratory, and epidemiological data into clear, decision-ready intelligence for public health response teams.
You can systematically map ethical tensions inherent in public health policy decisions—such as individual autonomy versus collective benefit, liberty versus security, and efficiency versus equity. This skill identifies which populations bear disproportionate burdens, surfaces hidden value assumptions, and documents ethical reasoning transparent enough to withstand legal scrutiny and build stakeholder trust. You'll produce policy ethics memos suitable for agency leadership, legislative testimony, or public comment.
Generate regulatory-compliant policy documents, map complex interagency compliance obligations, and prepare comprehensive federal compliance documentation for audits and funding applications. You'll receive standards-aligned policy language, requirement cross-references, and compliance checklists ready for internal review and submission.
You can create personalized, actionable chronic disease prevention interventions grounded in behavior change science. Claude analyzes patient risk factors, selects appropriate evidence-based frameworks (like TTM or Social Cognitive Theory), and generates detailed prevention plans with specific behavioral targets, motivational strategies, and outcome metrics. You get structured assessment protocols and intervention templates ready to implement with your patients.
Design comprehensive chronic disease prevention interventions that integrate behavior change theory with population-specific tailoring. You'll generate evidence-based strategies for diabetes, heart disease, obesity, and other chronic conditions, complete with implementation blueprints and measurable health outcomes. Each intervention is customized for your target population's demographics, social determinants, and readiness to change.
This skill helps you architect comprehensive workplace wellness initiatives grounded in evidence-based practices and organizational psychology. You'll create tailored programs that align with your company culture, address employee health needs, and deliver measurable outcomes like improved engagement, reduced absenteeism, and enhanced wellbeing metrics. The output includes strategic frameworks, implementation roadmaps, success metrics, and ROI projections.
This skill generates detailed, customized emergency preparedness plans tailored to your specific location, threats, and organizational needs. It creates actionable response protocols, supply checklists, communication procedures, and evacuation strategies. You get a complete, ready-to-implement emergency framework for households, businesses, schools, or community organizations.